Steven A. Rosenberg

发表

Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis.

S. Rosenberg, K. Csaky, J. Yang, 2004, Journal of immunotherapy.

Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.

S. Rosenberg, P. Hwu, M. Nishimura, 1999, Journal of immunology.

Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression

M. Parkhurst, A. Gros, A. Pasetto, 2016, Clinical Cancer Research.

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

F. Marincola, S. Rosenberg, N. Restifo, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

S. Rosenberg, K. Irvine, N. Restifo, 1996, Journal of immunology.

Antigen processing in vivo and the elicitation of primary CTL responses.

R. Anderson, J. Yewdell, J. Bennink, 1995, Journal of immunology.

Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases

R. Royal, J. Lam, M. Do, 1997 .

Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer.

S. Rosenberg, P. Hwu, M. Dudley, 2000, Human gene therapy.

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain

S. Rosenberg, P. Hwu, Z. Eshhar, 1993, The Journal of experimental medicine.

T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy

F. Darvishian, N. Restifo, Katelyn McGary, 2013, Proceedings of the National Academy of Sciences.

Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines.

F. Marincola, J. Mulé, P. Fetsch, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.

Walker S. Lahr, Beau R. Webber, T. Bürckstümmer, 2022, Med.

clinical implications of basic research Shedding Light on Immunotherapy for Cancer

S. Rosenberg, Steven A. Rosenberg, 2004 .

T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes.

S. Rosenberg, M. Dudley, J. Wunderlich, 2000, Cancer journal.

Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads to a functionally heterogeneous CTL response.

S. Rosenberg, M. Nishimura, M. Dudley, 1999, Journal of immunotherapy.

Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma.

E. Wang, P. Fetsch, A. Abati, 1999, Cancer detection and prevention.

T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.

S. Rosenberg, M. Nishimura, Y. Kawakami, 1994, Proceedings of the National Academy of Sciences of the United States of America.